Alnylam Pharmaceuticals (ALNY) Assets Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.52% |
| Dec 31, 2025 | 7.83% |
| Sep 30, 2025 | 7.97% |
| Jun 30, 2025 | 6.24% |
| Mar 31, 2025 | 13.07% |
| Dec 31, 2024 | 12.10% |
| Sep 30, 2024 | 10.59% |
| Jun 30, 2024 | 8.10% |
| Mar 31, 2024 | 13.68% |
| Dec 31, 2023 | 19.45% |
| Sep 30, 2023 | 18.03% |
| Jun 30, 2023 | 13.71% |
| Mar 31, 2023 | 12.02% |
| Dec 31, 2022 | 12.20% |
| Sep 30, 2022 | 21.08% |
| Jun 30, 2022 | 18.35% |
| Mar 31, 2022 | 24.80% |
| Dec 31, 2021 | 23.60% |
| Sep 30, 2021 | 21.47% |
| Jun 30, 2021 | 20.49% |
| Mar 31, 2021 | 19.84% |
| Dec 31, 2020 | 19.70% |
| Sep 30, 2020 | 18.16% |
| Jun 30, 2020 | 17.13% |
| Mar 31, 2020 | 6.95% |
| Dec 31, 2019 | 17.28% |
| Sep 30, 2019 | 20.84% |
| Jun 30, 2019 | 21.34% |
| Mar 31, 2019 | 13.27% |
| Dec 31, 2018 | 30.22% |
| Sep 30, 2018 | 30.22% |
| Jun 30, 2018 | 31.07% |
| Mar 31, 2018 | 32.46% |
| Dec 31, 2017 | 47.31% |
| Sep 30, 2017 | 33.33% |
| Jun 30, 2017 | 35.12% |
| Mar 31, 2017 | 27.22% |
| Dec 31, 2016 | 34.97% |
| Sep 30, 2016 | 33.45% |
| Jun 30, 2016 | 32.31% |
| Mar 31, 2016 | 28.97% |
| Dec 31, 2015 | 28.66% |
| Sep 30, 2015 | 28.33% |
| Jun 30, 2015 | 28.31% |
| Dec 31, 2014 | 17.53% |